Home » SG biotech firm Mirxes reports 70% revenue drop in FY 2022, prospectus revealsSG biotech firm Mirxes reports 70% revenue drop in FY 2022, prospectus reveals Cheapest Gadget August 5, 2023 All No CommentsThe company wants to develop a “super app” for precision multi-omics testing in Southeast Asia…Read More Tweet Pin It Related Posts Buy Biotech Stocks? Cathie Wood’s Ark Thinks So (And, Here’s Why) Two biotech CEOs charged with defrauding investors The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion EurosAbout The Author Cheapest Gadget
The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros
